3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
8
Colonic Neoplasms
5
Motor Activity
3
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Neoplasms
2
Weight Loss
1
Urologic Neoplasms
1
Smoking Cessation
1
Sarcopenia
1
Recurrence
1
Rectal Neoplasms
1
Polyps
1
Patient Compliance
1
Pancreatitis, Chronic
1
Lung Neoplasms
1
Gastrointestinal Neoplasms
1
Esophageal Neoplasms
1
Duodenal Neoplasms
1
Diabetes Mellitus, Type 2
1
Colorectal Cancer Prevention
1
Cholangiocarcinoma
1
Breast Neoplasms
1
Anastomotic Leak
1
Interventions
Blood Specimen Collection
2
voglibose
1
saxagliptin
1
repaglinide
1
miglitol
1
metahexamide
1
meglitinide
1
glymidine
1
glisoxepide
1
gliquidone
1
glimepiride
1
glibornuride
1
Vildagliptin
1
Urine Specimen Collection
1
Troglitazone
1
Tolbutamide
1
Tolazamide
1
Thiazolidinediones
1
Surveys and Questionnaires
1
Sulfonylurea Compounds
1
Sitagliptin Phosphate
1
Rosiglitazone
1
Plant Proteins
1
Pioglitazone
1
Phenformin
1
Nateglinide
1
Metformin
1
Liraglutide
1
Hypoglycemic Agents
1
Glycoside Hydrolase Inhibitors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Diabetes Mellitus, Type 2
×
Diet
×
Gastrointestinal
×
Clear all
NCT03206827
2021-09-27
ScenoProt
University of Helsinki
Phase NA
Completed
147 enrolled